Hyperaldosteronism among black and white subjects with resistant hypertension

Hypertension

Volumn 40, Issue 6, 2002, Pages 892-896

  Calhoun, David A ^b,e   Nishizaka, Mari K ^a   Zaman, Mohammad A ^a   Thakkar, Roopal B ^c   Weissmann, Paula ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c ST JOSEPH MERCY HOSPITAL   (United States)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^e 520 ZRB ^*  (United States)

Author keywords

Blacks; Diuretics; Hyperaldosteronism; Hypertension, essential; Renin

Indexed keywords

ALDOSTERONE; RENIN; SODIUM CHLORIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINARY EXCRETION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALABAMA; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; BLOOD PRESSURE; DIURETICS; DRUG RESISTANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RENIN; SENSITIVITY AND SPECIFICITY; SODIUM CHLORIDE, DIETARY; SPIRONOLACTONE;

EID: 0036898286     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000040261.30455.B6     Document Type: Article

References (26)

1. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol. 1994;21:315-318.
2. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: Plasma aldosterone-renin ratio. Am J Kidney Dis. 2001;37:699-705.
3. Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA. Evidence that primary aldosteronism may not be uncommon: 12% Incidence among antihypertensive drug trail volunteers. Clin Exp Pharmacol Physiol. 1993;20:296-298.
4. Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J. Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab. 2000;85:1863-1867.
5. Rayner BL, Opie LH, Davidson JS. The aldosterone/renin ratio as a screening test for primary aldosteronism. S Afr Med J. 2000;90:394-400.
6. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens. 2000;14:311-315.
7. Rayner BL, Myers JE, Opie LH, Trinder YA, Davidson JS. Screening for primary aldosteronism-normal ranges for aldosterone and renin in three South African population groups. S Afr Med J. 2001;91:594-599.
8. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet. 1999;353:40. Letter.
9. Loh K-C, Koay ES, Khaw M-C, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854-2859.
10. Holland OB, Brown H, Kuhnert L, Fairchild C, Risk M, Gomez-Sanchez G. Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension. 1984;6:717-723.
11. Lee MR, Critchley JA, Gordon CJ, Makaranada K, Sriwatanakul K, Balali-Mood M, Boye GL. Ethnic differences in the renal sodium dopamine relationship. A possible explanation for regional variations in the prevalence of hypertension? Am J Hypertens. 1990;3:100S-103S.
12. Falkner B. Differences in blacks and whites with essential hypertension: Biochemistry and endocrine. State of the Art Lecture. Hypertension. 1990; 15:681-686.
13. Somova L, Mufunda J. Ethnic differences of renin-sodium profile and renal prostaglandins in the pathogenesis of systemic arterial hypertension. Cent Afr J Med, 1996;42:170-175.
14. Thakkar RB, Oparil S. Primary aldosteronism: A practical approach to diagnosis and treatment. J Clin Hypertens. 2001;3:189-195.
15. Young WF Jr. Primary aldosteronism: A common and curable form of hypertension. Cardiol Rev. 1999;7:207-214.
16. Streeten DHP, Tomycz N, Anderson GH. Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med. 1979;67:403-413.
17. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch Intern Med. 1981;141:1589-1593.
18. Weinberger MH, Fineberg NS. The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med. 1993;153:2125-2129.
19. Oelkers W, Diederich S, Bähr V. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney disease. J Clin Endocrinol Metab. 2000;85:3266-3270.
20. Stowasser M. Primary aldosteronism: Rare bird or common cause of secondary hypertension? Curr Hypertens Reports. 2001;3:230-239.
21. McAlister FA, Lewanczuk RZ. Primary hyperaldosteronism and adrenal incidentaloma: An argument for physiological testing before adrenalectomy. Can J Surg. 1998;41:299-305.
22. Fiquet-Kempf B, Launay-Mignot P, Borbrie G, Plouin P-F. Is primary aldosteronism underdiagnosed in clinical practice? Clin Exp Pharmacol Physiol. 2001;28:1083-1086.
23. Kaplan NM. Cautions over the current epidemic of primary aldosteronism. Lancet. 2000;357:953-954.
24. Kaplan NM. Caution about the overdiagnosis of primary aldosteronism. Mayo Clin Proc. 2001;76:875-876.
25. Connell JMC. Is there an epidemic of primary aldosteronism? J Hum Hypertens. 2002;16:151-152.
26. Padfield PL. Primary aldosteronism, a common entity? The myth persists. J Hum Hypertens. 2002;16:159-162.